|
Vasocon-aDrug - Vasocon-a The trade name of the product as shown on the labeling.
Dosage -
SOLUTION/DROPS; OPHTHALMIC
Active Ingredient(s) -
Antazoline Phosphate; Naphazoline Hydrochloride
Strength -
0.5%;0.05%
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
018746
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Jul 11, 1994
Reference Listed Drug (RLD) -
Yes
Type -
OTC
Applicant Full Name -
Novartis Pharmaceuticals Corp
Vasocon-a
Valpin 50 50mg Tablet; Oral
Vasocon-a 0.5%;0.05% Solution/drops; Ophthalmic Anagrelide Hcl Eq 1mg Base Capsule; Oral Anagrelide Hcl Eq 0.5mg Base Capsule; Oral Anagrelide Hcl Eq 1mg Base Capsule; Oral Arimidex 1mg Tablet; Oral Leritine Eq 25mg Base Tablet; Oral Leritine 25mg/ml Injectable; Injection Miradon 50mg Tablet; Oral Anisotropine Methylbromide 50mg Tablet; Oral NewDrugInformation |